Neoadjuvant nivolumab, gemcitabine and cisplatin in muscle-invasive bladder cancer: Study update

被引：0
|
作者：
Gupta, Shilpa
Weight, Christopher J.
Agarwal, Neeraj
Gupta, Sumati
Konety, Badrinath
Gibb, Ewan
Davicioni, Elai
Thyagarajan, Bharat
Sonpavde, Guru
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Univ Utah, Salt Lake City, UT USA
[3] GenomeDx Biosci, Vancouver, BC, Canada
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-A008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A008
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
    Kaneko, Gou
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Obata, Jun
    Nakamura, So
    Miyajima, Akira
    Oya, Mototsugu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
  • [2] Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
    Kim, Hongsik
    Jeong, Byong Chang
    Hong, Joohyun
    Kwon, Ghee Young
    Kim, Chan Kyo
    Park, Won
    Pyo, Hongryull
    Song, Wan
    Sung, Hyun Hwan
    Hong, Jung Yong
    Park, Se Hoon
    CANCER RESEARCH AND TREATMENT, 2023, 55 (02): : 636 - 642
  • [3] Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
    Narayan, Vivek
    Mamtani, Ronac
    Keefe, Stephen
    Guzzo, Thomas
    Malkowicz, S. Bruce
    Vaughn, David J.
    CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 1084 - 1091
  • [4] Neoadjuvant chemotherapy with gemcitabine and cisplatin for muscle-invasive bladder cancer: multicenter retrospective study
    Okabe, Ko
    Shindo, Tetsuya
    Maehana, Takeshi
    Nishiyama, Naotaka
    Hashimoto, Kohei
    Itoh, Naoki
    Takahashi, Atsushi
    Taguchi, Keisuke
    Tachiki, Hitoshi
    Tanaka, Toshiaki
    Masumori, Naoya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (10) : 934 - 941
  • [5] Camrelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
    Xing, N.
    Han, S.
    Jiang, J.
    Xu, W.
    Shi, B.
    Ping, H.
    Ji, Z.
    Ma, Q.
    Wang, H.
    Chen, S.
    Wang, W.
    Fan, X.
    Zhou, Q.
    Zhang, W.
    ANNALS OF ONCOLOGY, 2021, 32 : S714 - S714
  • [6] Tislelizumab with gemcitabine and cisplatin as a neoadjuvant regimen for muscle-invasive bladder cancer: case series
    Wang, Ze
    Wang, Yapeng
    Wang, Shuo
    Ran, Qiang
    Peng, Song
    Zhang, Yao
    Zhang, Jun
    Zhang, Dianzheng
    Wang, Luofu
    Lan, Weihua
    Liu, Qiuli
    Jiang, Jun
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (01): : 245 - 251
  • [7] CISPLATIN AND GEMCITABINE NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTITUTE EXPERIENCE
    Verri, Elena
    Mascia, Roberta
    Rocca, Maria Cossu
    Aurilio, Gaetano
    Cullura, Daniela
    Musi, Gennaro
    Cozzi, Gabriele
    Di Trapani, Ettore
    Russo, Andrea
    De Cobelli, Ottavio
    Nole, Franco
    ANTICANCER RESEARCH, 2018, 38 (04) : 2515 - 2518
  • [8] Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer
    Meleis, Laura
    Moore, Russell
    Inman, Brant A.
    Harrison, Michael R.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 330 - 337
  • [9] Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
    Yafi, Faysal A.
    Kassouf, Wassim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 747 - 752
  • [10] Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer.
    Lattanzi, Michael
    Solovyov, Alexander
    Lihm, Jayon
    Quinlan, Colleen
    Whiting, Karissa
    Li, Hao
    Al-Ahmadie, Hikmat A.
    Teo, Min Yuen
    Aggen, David Henry
    Ostrovnaya, Irina
    Regazzi, Ashley Marie
    Jihad, Marwah
    Bajorin, Dean F.
    Balar, Arjun Vasant
    Mortazavi, Amir
    Merghoub, Taha
    Iyer, Gopa
    Rosenberg, Jonathan E.
    Greenbaum, Benjamin
    Funt, Samuel Aaron
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345